Biosafety of Mesoporous Silica Nanoparticles

Careful analysis of any new nanomedicine device or disposal should be undertaken to comprehensively characterize the new product before application, so that any unintended side effect is minimized. Because of the increasing number of nanotechnology-based drugs, we can anticipate that regulatory auth...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biomimetics (Basel)
Autori principali: Rascol, Estelle, Pisani, Cédric, Dorandeu, Christophe, Nyalosaso, Jeff L., Charnay, Clarence, Daurat, Morgane, Da Silva, Afitz, Devoisselle, Jean-Marie, Gaillard, Jean-Charles, Armengaud, Jean, Prat, Odette, Maynadier, Marie, Gary-Bobo, Magali, Garcia, Marcel, Chopineau, Joël, Guari, Yannick
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2018
Soggetti:
Perspective
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352691/
https://ncbi.nlm.nih.gov/pubmed/31105244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomimetics3030022
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi